- STAT+: A year after distressed buyout, what’s become of Bluebird Bio?Bluebird Bio was a dark biotech morality tale when David Meek bought it. He says the new company, Genetix, is already making money.STAT · 23d ago↗ source
- The new presidential fitness test is a positive step, not the solution, experts sayPhysical activity needs to be fun to keep kids engaged. And the test risks embarrassing them, instead.STAT · 23d ago↗ source
- STAT+: A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker?The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by their doctor.STAT · 23d ago↗ source